AVEO Pharmaceuticals Inc
Biotechnology
Healthcare
AVEO
34.48 M shares
NASDAQ US
traded
19 Jan 2023
listed
yes
open
15.00
52 week high
15.00
high
15.00
52 week low
3.15
low
14.99
growth
343.79 %
previous Close
15.00
P/E ratio
market cap
269 M
div yield
0
net incoming
-8.32 M
-83.00 %
net profit margin
-33.27 %
16.00 %
operating incoming
-7.15 M
-79.00 %
net change in cash
-3.68 M
-211.32 %
cash on hand
70.17 M
-4.98 %
cost of revenue
3.07 M
153.00 %
top